7.22 USD
-0.07 (-0.96%)
7.22 USD
0 (0%)
We assign a fundamental rating of 6 out of 10 to VMD. VMD was compared to 100 industry peers in the Health Care Providers & Services industry. VMD has only an average score on both its financial health and profitability. VMD is growing strongly while it is still valued neutral. This is a good combination! This makes VMD very considerable for growth investing!
1. Profitability
1.1 Basic Checks
In the past year VMD was profitable.
In the past year VMD had a positive cash flow from operations.
In the past 5 years VMD has always been profitable.
VMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
VMD's Return On Assets of 6.73% is amongst the best of the industry. VMD outperforms 88.00% of its industry peers.
The Return On Equity of VMD (10.19%) is better than 73.00% of its industry peers.
The Return On Invested Capital of VMD (7.79%) is better than 74.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VMD is in line with the industry average of 9.44%.
The last Return On Invested Capital (7.79%) for VMD is above the 3 year average (7.66%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.73% | ||
| ROE | 10.19% | ||
| ROIC | 7.8% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
The Profit Margin of VMD (5.34%) is better than 79.00% of its industry peers.
VMD's Profit Margin has declined in the last couple of years.
VMD has a better Operating Margin (6.83%) than 70.00% of its industry peers.
In the last couple of years the Operating Margin of VMD has declined.
With a decent Gross Margin value of 57.89%, VMD is doing good in the industry, outperforming 80.00% of the companies in the same industry.
In the last couple of years the Gross Margin of VMD has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.83% | ||
| PM (TTM) | 5.34% | ||
| GM | 57.89% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
VMD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for VMD has been increased compared to 1 year ago.
The number of shares outstanding for VMD has been increased compared to 5 years ago.
The debt/assets ratio for VMD has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.67 indicates that VMD is not in any danger for bankruptcy at the moment.
VMD's Altman-Z score of 4.67 is amongst the best of the industry. VMD outperforms 83.00% of its industry peers.
The Debt to FCF ratio of VMD is 3.93, which is a good value as it means it would take VMD, 3.93 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of VMD (3.93) is better than 72.00% of its industry peers.
A Debt/Equity ratio of 0.15 indicates that VMD is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.15, VMD is doing good in the industry, outperforming 72.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.93 | ||
| Altman-Z | 4.67 |
ROIC/WACC0.88
WACC8.9%
2.3 Liquidity
VMD has a Current Ratio of 1.13. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.13, VMD is not doing good in the industry: 62.00% of the companies in the same industry are doing better.
VMD has a Quick Ratio of 1.01. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of VMD (1.01) is worse than 65.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 22.22% over the past year.
VMD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.01% yearly.
The Revenue has grown by 18.90% in the past year. This is quite good.
The Revenue has been growing by 22.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
Revenue 1Y (TTM)18.9%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
3.2 Future
VMD is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 30.77% yearly.
Based on estimates for the next years, VMD will show a quite strong growth in Revenue. The Revenue will grow by 19.73% on average per year.
EPS Next Y31.66%
EPS Next 2Y35.63%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue Next Year19.16%
Revenue Next 2Y18.3%
Revenue Next 3Y19.73%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 21.88 indicates a rather expensive valuation of VMD.
65.00% of the companies in the same industry are more expensive than VMD, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of VMD to the average of the S&P500 Index (26.54), we can say VMD is valued inline with the index average.
A Price/Forward Earnings ratio of 14.02 indicates a correct valuation of VMD.
Based on the Price/Forward Earnings ratio, VMD is valued a bit cheaper than the industry average as 79.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.78, VMD is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.88 | ||
| Fwd PE | 14.02 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VMD is valued cheaper than 89.00% of the companies in the same industry.
VMD's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 50.98 | ||
| EV/EBITDA | 6.41 |
4.3 Compensation for Growth
VMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
VMD has a very decent profitability rating, which may justify a higher PE ratio.
VMD's earnings are expected to grow with 30.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)5.45
EPS Next 2Y35.63%
EPS Next 3Y30.77%
5. Dividend
5.1 Amount
VMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
7.22
-0.07 (-0.96%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners66.48%
Inst Owner ChangeN/A
Ins Owners13.52%
Ins Owner Change1%
Market Cap274.50M
Revenue(TTM)254.79M
Net Income(TTM)13.61M
Analysts80
Price Target13.26 (83.66%)
Short Float %1.24%
Short Ratio2.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)0
Avg EPS beat(4)-2.17%
Min EPS beat(4)-5.7%
Max EPS beat(4)-0.99%
EPS beat(8)1
Avg EPS beat(8)-9.3%
EPS beat(12)3
Avg EPS beat(12)-5.6%
EPS beat(16)4
Avg EPS beat(16)-6.65%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.11%
Max Revenue beat(2)-1.06%
Revenue beat(4)1
Avg Revenue beat(4)-1.33%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.24%
Revenue beat(8)5
Avg Revenue beat(8)-0.38%
Revenue beat(12)7
Avg Revenue beat(12)-0.14%
Revenue beat(16)11
Avg Revenue beat(16)0.61%
PT rev (1m)-4.88%
PT rev (3m)-4.88%
EPS NQ rev (1m)18.18%
EPS NQ rev (3m)8.33%
EPS NY rev (1m)0.46%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)-1.9%
Revenue NQ rev (3m)3.12%
Revenue NY rev (1m)0.7%
Revenue NY rev (3m)0.7%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.88 | ||
| Fwd PE | 14.02 | ||
| P/S | 1.08 | ||
| P/FCF | 50.98 | ||
| P/OCF | 5.66 | ||
| P/B | 2.05 | ||
| P/tB | 3.72 | ||
| EV/EBITDA | 6.41 |
EPS(TTM)0.33
EY4.57%
EPS(NY)0.52
Fwd EY7.13%
FCF(TTM)0.14
FCFY1.96%
OCF(TTM)1.27
OCFY17.65%
SpS6.7
BVpS3.51
TBVpS1.94
PEG (NY)0.69
PEG (5Y)5.45
Graham Number5.11
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.73% | ||
| ROE | 10.19% | ||
| ROCE | 11% | ||
| ROIC | 7.8% | ||
| ROICexc | 8.38% | ||
| ROICexgc | 14.13% | ||
| OM | 6.83% | ||
| PM (TTM) | 5.34% | ||
| GM | 57.89% | ||
| FCFM | 2.11% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexgc growth 3Y2.65%
ROICexgc growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score5
Asset Turnover1.26
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.15 | ||
| Debt/FCF | 3.93 | ||
| Debt/EBITDA | 0.44 | ||
| Cap/Depr | 157.16% | ||
| Cap/Sales | 16.91% | ||
| Interest Coverage | 21.97 | ||
| Cash Conversion | 108.16% | ||
| Profit Quality | 39.56% | ||
| Current Ratio | 1.13 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 4.67 |
F-Score5
WACC8.9%
ROIC/WACC0.88
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)22.22%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%-10%
EPS Next Y31.66%
EPS Next 2Y35.63%
EPS Next 3Y30.77%
EPS Next 5YN/A
Revenue 1Y (TTM)18.9%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%23.98%
Revenue Next Year19.16%
Revenue Next 2Y18.3%
Revenue Next 3Y19.73%
Revenue Next 5YN/A
EBIT growth 1Y7.34%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year222.66%
EBIT Next 3Y64.45%
EBIT Next 5YN/A
FCF growth 1Y-66.11%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y22.32%
OCF growth 3Y20.23%
OCF growth 5Y15.41%
VIEMED HEALTHCARE INC / VMD FAQ
What is the ChartMill fundamental rating of VIEMED HEALTHCARE INC (VMD) stock?
ChartMill assigns a fundamental rating of 6 / 10 to VMD.
What is the valuation status for VMD stock?
ChartMill assigns a valuation rating of 6 / 10 to VIEMED HEALTHCARE INC (VMD). This can be considered as Fairly Valued.
Can you provide the profitability details for VIEMED HEALTHCARE INC?
VIEMED HEALTHCARE INC (VMD) has a profitability rating of 6 / 10.
What is the earnings growth outlook for VIEMED HEALTHCARE INC?
The Earnings per Share (EPS) of VIEMED HEALTHCARE INC (VMD) is expected to grow by 31.66% in the next year.